Home/Passage Bio/Bruce Goldsmith
BG

Bruce Goldsmith

President and Chief Executive Officer

Passage Bio

Passage Bio Pipeline

DrugIndicationPhase
PBFT02Frontotemporal Dementia (FTD) with progranulin (GRN) gene mutationsPhase 1/2
PBGM01Infantile GM1 GangliosidosisPhase 1/2